Skip to Content

View Additional Section Content

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) Vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT03258554?term=hn004&rank=1

Clinical Trial Categories

  • Head and Neck Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM